These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1486116)

  • 1. Looking for the signal of life: thallium-201, 99mTc-sestamibi, PET and echocardiography in the assessment of myocardial viability.
    Marzullo P; Parodi O
    J Nucl Biol Med (1991); 1992; 36(3):241-2. PubMed ID: 1486116
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of myocardial viability: where are we?
    McKillop JH
    Nucl Med Commun; 1994 Dec; 15(12):935-6. PubMed ID: 7715890
    [No Abstract]   [Full Text] [Related]  

  • 3. Myocardial viability estimated with 18F-FDG PET in patients with severe angina and 201Tl and 99mTc MIBI SPECT perfusion defects.
    Ahonen A; Voipio-Pulkki LM; Ruotsalainen U; Parviainen S; Ylinen SL; Haaparanta M; Korkeila P; Wegelius U
    Acta Radiol Suppl; 1991; 376():135-6. PubMed ID: 1666750
    [No Abstract]   [Full Text] [Related]  

  • 4. Myocardial viability.
    Hendel RC; Chaudhry FA; Bonow RO
    Curr Probl Cardiol; 1996 Mar; 21(3):145-221. PubMed ID: 8654119
    [No Abstract]   [Full Text] [Related]  

  • 5. The new 99mTc myocardial perfusion imaging agents: 99mTc-sestamibi and 99mTc-teboroxime.
    Berman DS; Kiat H; Maddahi J
    Circulation; 1991 Sep; 84(3 Suppl):I7-21. PubMed ID: 1832100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The methodologies of nuclear medicine imaging in the study of the myocardium at risk: the hibernating myocardium].
    Marzullo P; Sambuceti G; Gimelli A; Giorgetti A; Parodi O
    G Ital Cardiol; 1993 May; 23(5):533-40. PubMed ID: 8339880
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative feasibility of separate or simultaneous rest thallium-201/stress technetium-99m-sestamibi dual-isotope myocardial perfusion SPECT.
    Kiat H; Germano G; Friedman J; Van Train K; Silagan G; Wang FP; Maddahi J; Berman D
    J Nucl Med; 1994 Apr; 35(4):542-8. PubMed ID: 8151372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Myocardial perfusion visualized with SPECT: three-dimensional representation].
    Ferretti PP; Salvo D; Serafini D; Versari A; Casali G; Borasi G
    Radiol Med; 1989; 78(1-2):18-22. PubMed ID: 2789416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial viability: what do we need?
    Schoeder H; Friedrich M; Topp H
    Eur J Nucl Med; 1993 Sep; 20(9):792-803. PubMed ID: 8223775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of myocardial viability by isotopic methods].
    Latre Romero JM; Vallés Belsué F
    Rev Esp Cardiol; 1994; 47 Suppl 4():116-23. PubMed ID: 7863076
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison between myocardial perfusion scintigraphy with thallium-201 and technetium-99m-Sestamibi (methoxy isobutyl isonitrile) for the detection of coronary atherosclerotic disease].
    Taillefer R; Lambert R; Grégoire J; Essiambre R; Phaneuf DC
    Union Med Can; 1990; 119(6):322, 324, 326-9. PubMed ID: 2150134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial perfusion studies: new agents, new methodologies.
    de Sá EP
    Rev Port Cardiol; 1993 Dec; 12(12):1065-72. PubMed ID: 8117461
    [No Abstract]   [Full Text] [Related]  

  • 13. A clinical case illustrating the current diagnostic modalities for myocardial viability assessment.
    Lipke CS; Schaefer WM; Koch KCh; Kühl HP
    Nuklearmedizin; 2004 Jun; 43(3):N32-3. PubMed ID: 15250106
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of hypoxia and ouabain effects on the myocardial uptake kinetics of technetium-99m hexakis 2-methoxyisobutyl isonitrile and thallium-201.
    Meerdink DJ; Leppo JA
    J Nucl Med; 1989 Sep; 30(9):1500-6. PubMed ID: 2527973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of the technetium-99m/thallium-201 overlap in acute myocardial infarction].
    Umezawa S; Obayashi T; Chun YH; Adachi H; Kanayama M; Korenaga M; Inada M; Taniguchi K
    J Cardiol; 1989 Dec; 19(4):981-90. PubMed ID: 2562093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New ways to scan the myocardium.
    Med Lett Drugs Ther; 1991 Sep; 33(853):87-9. PubMed ID: 1832204
    [No Abstract]   [Full Text] [Related]  

  • 17. Thallium-201 and technetium-99m-sestamibi for assessing viable myocardium.
    Bonow RO; Dilsizian V
    J Nucl Med; 1992 May; 33(5):815-8. PubMed ID: 1533248
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of viable myocardium with technetium-99m-MIBI infusion.
    Worsley DF; Fung AY; Jue J; Burns RJ
    J Nucl Med; 1995 Jun; 36(6):1037-9. PubMed ID: 7769424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile.
    Cuocolo A; Pace L; Ricciardelli B; Chiariello M; Trimarco B; Salvatore M
    J Nucl Med; 1992 Apr; 33(4):505-11. PubMed ID: 1552332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reversibility in perfusion scintigraphy after myocardial infarct: a comparison between the protocol of single-day rest-stress with 99mTc sestamibi and reinjection with thallium-201].
    Ferreira J; Gil VM; Ventosa A; Calqueiro J; Seabra-Gomes R
    Rev Port Cardiol; 1993 Dec; 12(12):1013-21, 999. PubMed ID: 8117454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.